Candel Therapeutics CADL
NASDAQ CADL
$10.18 +0.02 (+0.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Candel Therapeutics (CADL) Asset Writedowns and Impairment (2023 - 2025)

Updated

Candel Therapeutics (CADL) posted Asset Writedowns and Impairment of $7,000 for Q4 2025, down 82.9% from $41,000 a year earlier but up 600.0% from the prior quarter.

Analysis

Candel Therapeutics (CADL) Asset Writedowns and Impairment (2023 - 2025) Analysis & Trends

For FY2025, Candel Therapeutics' Asset Writedowns and Impairment came in at $90,000, up 119.5% from FY2024.

  • In prior years, Candel Therapeutics' Asset Writedowns and Impairment was $41,000 in FY2024 (-89.5%) and $390,000 in FY2023.
  • Quarterly Asset Writedowns and Impairment has run from a low of $1,000 in Q3 2025 to a high of $228,000 in Q4 2023 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Candel Therapeutics 774.88 Mn 774.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 7,000.00
Sep 30, 2025 1,000.00
Dec 31, 2024 41,000.00
Dec 31, 2023 228,000.00
API Access

Candel Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=CADL&period=max&api_key=YOUR_API_KEY